Survival and treatment pattern of non-small cell lung cancer over 20 years

Journal of Thoracic Oncology

Volumn 4, Issue 4, 2009, Pages 492-498

  Pitz, Marshall W ^a,b   Musto, Grace ^a   Demers, Alain A ^a,b   Kliewer, Erich V ^a,b   Navaratnam, Srisala ^a,b  

^a CANCERCARE MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Lung neoplasm; Non small cell lung carcinoma; Population; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL TIME; AGED; CANCER STAGING; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 67649402417     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31819846fb     Document Type: Article

References (51)

1. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392. (Pubitemid 38101633)
2. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(3 Suppl):29S-55S. (Pubitemid 47502798)
3. de Perrot M, Licker M, Robert J, Spiliopoulos A. Time trend in the surgical management of patients with lung carcinoma. Eur J Cardiothorac Surg 1999;15:433-437. (Pubitemid 29210344)
4. Waller DA. Surgery for non-small cell lung cancer-new trends. Lung Cancer 2001;34 (Suppl 2):S133-S136. (Pubitemid 33101857)
5. Sherwood JT, Brock MV. Lung cancer: new surgical approaches. Respirology 2007;12:326-332. (Pubitemid 47164785)
6. Purdy JA. From new frontiers to new standards of practice: advances in radiotherapy planning and delivery. Front Radiat Ther Oncol 2007;40: 18-39.
7. Aird EGA, Conway J. CT simulation for radiotherapy treatment planning. Br J Radiol 2002;75:937-949. (Pubitemid 36149758)
8. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-263.
9. Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006. (Pubitemid 46638932)
10. Clinical practice guidelines for the treatment of unresectable non-smallcell lung cancer. J Clin Oncol 1997;15:2996-3018. (Pubitemid 27330028)
11. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311: 899-909.
12. Manegold C. Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer 2001;34(Suppl 2):S165-S170. (Pubitemid 33101862)
13. Potosky AL, Saxman S, Wallace RB, Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 2004; 22:3261-3268. (Pubitemid 41103681)
14. Belanger A, Martel L, Caron-Malenfant E. Statistics Canada: Population Projections for Canada, Provinces and Territories 2005-2031. Ottawa, Ontario: Statistics Canada, 2005.
15. Roos NP, Shapiro E. Health and health care: experience with a population- based health information system. Med Care 1995;33(12 Supplement): DS1-DS146.
16. Chen VW, Wu XC. Incidence, Cancer in North America, 1991-1995. Sacramento, CA: North American Association of Central Cancer Registries (NAACCR), 1999.
17. Greene FL, Compton CC. AJCC Cancer Staging Atlas. New York, NY: Springer, 2006.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19:335-351.
19. Gilmore J. Report on Smoking in Canada, 1985 to 2001. Stats Canada Catalogue 82F007XIE, www.statcan.ca 2002. Accessed November 13, 2008.
20. Shields M. Smoking - prevalence, bans and exposure to second hand smoke. Health Reports 2007;18:67-85.
21. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics, 2007.
22. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the Surveillance, Epidemiology, and End Results Database. J Clin Oncol 2007;25:5570-5577.
23. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-1243.
24. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-1608.
25. Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage iii non-small-cell lung cancer. J Clin Oncol 2005;23:3257-3269. (Pubitemid 46211350)
26. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2000; CD002142.
27. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small- cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633-641. (Pubitemid 18106155)
28. Marino P, Pampallona S, Preatoni A, Cantoni A, Invernizzi F. Chemotherapy vs supportive care in advanced non-small-cell lung cancer: results of a meta-analysis of the literature. Chest 1994;106:861-865. (Pubitemid 24278896)
29. Earle CC, Venditti LN, Neumann PJ, et al. Who gets chemotherapy for metastatic lung cancer? Chest 2000;117:1239-1246. (Pubitemid 30321574)
30. Ramsey SD, Howlader N, Etzioni RD, Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small cell lung cancer: evidence from Surveillance, Epidemiology and End Results- Medicare. J Clin Oncol 2004;22:4971-4978. (Pubitemid 46638623)
31. Foeglé J, Hédelin G, Lebitasy MP, Purohit A, Velten M, Quoix E. Non-small cell lung cancer in a French department, (1982-1997): management and outcome. Br J Cancer 2005;92:459-466. (Pubitemid 40403033)
32. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population-based study. Thorax 2001;56:212-217. (Pubitemid 32260665)
33. Le Chevalier T. Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2003;22:abstract 6.
34. Arriagada R, Bergman B, Dunant A, Le CT, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360. (Pubitemid 38101630)
35. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597. (Pubitemid 41007845)
36. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage iii non-small-cell lung cancer. J Clin Oncol 1999;17:2692. (Pubitemid 29415225)
37. Curran Jr W, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for patients (Pts) with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc Am Soc Clin Oncol 2000;19: abstract 1891.
38. Curran Jr W, Scott C, Langer C, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003;22:abstract 2499.
39. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-530.
40. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Canc Inst 1994;86:1766-1770. (Pubitemid 24373451)
41. Ludbrook JJ, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 2003;55:1321-1330.
42. Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002;20:1786-1792. (Pubitemid 34273267)
43. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 2006;24:413-418. (Pubitemid 46630461)
44. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-1205. (Pubitemid 29480659)
45. Sioris T, Sihvo E, Sankila R, Salo J. Effect of surgical volume and hospital type on outcome in non-small cell lung cancer surgery: a Finnish population-based study. Lung Cancer 2007;59:119-125.
46. Breathnach OS, Friedlin B, Conley B, et al. Twenty-two years of phase iii trials for patients with advanced non-small cell lung cancer: sobering results. J Clin Oncol 2001;19:1734-1742. (Pubitemid 32230875)
47. Pfister DG, Johnson DH, Azzoli CG, et al. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353. (Pubitemid 41095099)
48. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15). Int J Radiat Oncol Biol Phys 2002;54:719-728.
49. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489. (Pubitemid 28507400)
50. Aragoneses FG, Moreno N, Leon P, Fontan EG, Folque E. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002;36:59-63. (Pubitemid 34224896)
51. Bozcuk H, Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001;34:243-252. (Pubitemid 33010800)